BOTHELL, WA—October 6, 2011—Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, today announced that it will report the company's third quarter financial results on Tuesday, October 25, 2011 at the close of market and will host a conference call at 1:30 pm PT/4:30 ET. The call will be broadcast live and can be accessed via Sonosite's website at http://www.sonosite.com/about/investors.
A replay of the audio webcast will be available beginning October 25th at 4:30 pm PT and will be available until November 8th at 9:59 pm PT by dialing (719) 457-0820 or toll-free (888) 203-1112. The confirmation code 7745091 is required to access the replay. The call will also be archived on Sonosite's website.
About Sonosite
Sonosite, Inc. (www.sonosite.com) is the innovator and world leader in bedside and point-of-care ultrasound and an industry leader in ultra high-frequency micro-ultrasound technology and impedance cardiography equipment. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. Sonosite's small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care.… [Read more]
BOTHELL, WA - July 29, 2005 - Sonosite, Inc. (Nasdaq: SONO), the world leader in hand-carried ultrasound, today announced the appointments of Thomas J. Dugan as Senior Vice President, Marketing and Robert L. Massa as Vice President, Corporate Accounts.
Mr. Dugan brings 24 years of experience in marketing, sales, business development and operations in the medical device industry to Sonosite. He is currently a member of the Board of Directors for RITA Medical Systems, a medical device company focused on innovative oncology therapies, and a consultant to several medical device companies. From 2002 to 2004, Mr. Dugan was President of InterVascular, Inc., a subsidiary of Datascope Corporation and was a corporate officer of Datascope. He also served as corporate vice president of business development for Datascope from 2001 to 2002. From 1999 to 2001, Mr. Dugan was vice president of marketing for United States Surgical, a division of Tyco Healthcare, and responsible for their Auto Suture and USS/D&G Suture businesses. From 1996 to 1999, he headed business development for United States Surgical during a period when it made numerous acquisitions, investments and divestitures. Mr. Dugan has held management positions in sales, marketing and international with C.R. Bard, Puritan-Bennett and Johnson & Johnson.… [Read more]
Hand Carried Ultrasound System Is Honored In the "Facilities and Systems for Medical Institutions" Category BOTHELL, WA - November 18, 2005 - Sonosite, Inc. (Nasdaq:SONO), the world leader in hand-carried ultrasound, today announced that its MicroMaxx ultrasound system has won a 2005 Good Design Award (G-mark) in Japan. As one of 20 winning products in the category of "Facilities and Systems for Medical Institutions," the MicroMaxx system can display the G-Mark, a widely recognized label of design excellence in Japan and by designers worldwide.
Sponsored by the Japan Industrial Design Promotion Organization (JIDPO), a non-profit organization established by the Japanese Ministry of Economy, Trade and Industry, the annual competition has issued Good Design Awards for the past 50 years. The mission of the awards is to recognize those products that are expected to enrich peoples' lives through innovative design that advances society. Screening for this year's awards was conducted from July to September by a jury of designers, architects and others who represent the world of Japanese design and are at the forefront of their respective fields.… [Read more]
US and Canada's Space Agencies Testing Medical Technology In Ninth Undersea Mission BOTHELL, WA and TORONTO - November 28, 2005 ' Sonosite Inc. (Nasdaq:SONO), the world leader in hand-carried ultrasound, said today that the MicroMaxx system, the company's third generation ultrasound product, will be used to demonstrate that successful emergency treatment of a musculoskeletal injury during simulated space flight conditions can be accomplished with telementoring.
The test will be conducted during an 18-day experiment on the ninth mission of NASA Extreme Environment Mission Operations, or NEEMO 9, under 19 meters of water near Key Largo, Florida, in a habitat called Aquarius, which is analogous to a habitat that would house astronauts on the Earth's moon. Each aquanaut will use the notebook-sized MicroMaxx system to perform a diagnostic ultrasound of an injured knee prosthetic at the direction of radiologists and surgeons at the Center for Minimal Access Surgery at McMaster University in Ontario.… [Read more]
BOTHELL, WA - January 2, 2007 - Sonosite, Inc. (Nasdaq:SONO), the world leader in hand-carried ultrasound, announced today that Kevin M. Goodwin, Sonosite President and CEO will present at the 25th Annual JPMorgan Healthcare Conference at the Westin St. Francis in San Francisco on Tuesday, January 9, 2007 at 10:30 am (PT). A link to the audio-only webcast and replay will be available at http://ir.sonosite.com. The replay will be available beginning January 10, 2007 at 10:30 am (PT) and ending at midnight April 9, 2007.
About Sonosite
Sonosite, Inc. (www.sonosite.com) is the innovator and world leader in hand-carried ultrasound, with an installed base of more than 25,000 systems. The company, headquartered near Seattle, is represented by eight subsidiaries and a global distribution network in over 75 countries. Sonosite's small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high performance ultrasound to the point of patient care. The company employs approximately 500 people worldwide.… [Read more]
Transaction combines high-quality imaging technologies and pioneering point-of-care expertise to drive next generation medical imaging solutions
Tokyo, Japan / Bothell, WA, U.S. – December 15, 2011 – FUJIFILM Holdings Corporation (TSE: 4901, hereinafter: Fujifilm), a diversified technology company that operates in healthcare, highly functional materials, and document solutions, announced today that it has entered into a definitive agreement with Sonosite, Inc. (NASDAQ: SONO, hereinafter: Sonosite), a pioneer and leader in bedside and point-of-care ultrasound technology, pursuant to which Fujifilm will acquire Sonosite for approximately $995 million (which includes amounts payable in connection with its convertible debt). The transaction was unanimously approved by the Boards of Directors of both companies.… [Read more]
BOTHELL, WA - December 20, 2005 - Sonosite, Inc. (Nasdaq:SONO), the world leader in hand-carried ultrasound, said today that an independently conducted, random survey of MicroMaxx system customers showed that nearly all customers (97%) surveyed are highly satisfied overall with their MicroMaxx system and would recommend the system to their colleagues. Image quality, ease of use and system durability were key reasons for the high satisfaction rating, with 72% saying that the image quality of the MicroMaxx system is better than other ultrasound products they have used.… [Read more]
BOTHELL, WA - April 30, 2007 - Sonosite, Inc. (Nasdaq:SONO), the world leader in hand-carried ultrasound, today reported financial results for the first quarter ended March 31, 2007.
Worldwide revenue in the first quarter of 2007 grew 16% to $42.8 million compared with $36.9 million in the first quarter of 2006. For the first quarter of 2007, Sonosite reported a net loss of $563,000 or $0.03 per share, compared with a net loss of $363,000 or $0.02 per share in the prior year quarter.
"With a good start to the year, we are on track to achieve our revenue growth objectives for 2007," said Kevin M. Goodwin, Sonosite President and CEO. "Our international business which was up 25% compared to last year, showed positive, broad-based trends throughout our major markets and is benefiting from the investments we made in 2006 to increase sales capacity in several countries. Overall US revenue was up 7% for the quarter with much higher growth rates in our hospital point-of-care markets and enterprise business. The total growth rate was offset by sales in the private office channel, which we continue to develop. We are taking a number of steps to increase the effectiveness of this channel and expect to see our US business strengthen as we move through the year."
… [Read more]
BOTHELL, WA - December 20, 2010 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, said today that Kevin M. Goodwin, Sonosite’s President and CEO, will present at the 29th Annual JP Morgan Healthcare Conference being held at the Westin St. Francis Hotel in San Francisco, January 10-13, 2011.
The session will be webcast live on Wednesday, January 12, 2011 at 9:30 am Pacific Time. An audio replay will be available for 30 days following and can be accessed via Sonosite’s website at www.sonosite.com/investorinformation/webcasts.
About Sonosite
Sonosite, Inc. (www.sonosite.com) is the innovator and world leader in bedside and point-of-care ultrasound and an industry leader in ultra high-frequency micro-ultrasound technology and impedance cardiography equipment. Headquartered near Seattle, the company is represented by fourteen subsidiaries and a global distribution network in over 100 countries. Sonosite’s small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care.… [Read more]
US Revenue Up 17%
International Revenue Up 7%
VisualSonics Revenue Up 30%
Conference Call Webcast Live Today at 1:30 pm Pacific/4:30 pm Eastern
BOTHELL, WA - October 21, 2010 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, today reported financial results for the third quarter and nine months ended September 30, 2010.
REVENUE
Revenue increased 28% in the third quarter to $68.5 million and increased 18% for the nine months of 2010 to $186.1 million, as compared to the prior year.
Revenue included $8.7 million for the third quarter and nine months from the recently acquired VisualSonics (VSI).
Excluding VSI, revenue in the third quarter was $59.8 million, an increase of 12% compared to the third quarter of 2009, and $177.4 million, an increase of 12% for the nine months just ended.
… [Read more]
Revolutionary portable technology provides dynamic assessment of soft tissue and bone injuries
BOTHELL, WA - October 21, 2010 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, and the National Basketball Association (NBA), announced today a multiyear agreement to introduce Sonosite's ultrasound technology to the NBA's medical and athletic training professionals.
As part of the agreement, Sonosite will be the preferred provider of ultrasound products to the NBA and the NBA Development League (NBA D-League). This relationship will educate the NBA and NBA D-League's team physicians and athletic trainers about Sonosite's unique diagnostic ultrasound tools that are highly portable and can assist in efficiently diagnosing, treating, and monitoring the rehabilitation of professional athletes.
… [Read more]
BOTHELL, WA - October 14, 2010 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, today announced that its latest breakthrough in ultrasound imaging, Advanced Needle Visualization, will be featured at the American Society of Anesthesiologists 2010 Annual Meeting. This technology was first introduced in July 2010 and is a proprietary imaging algorithm that intensifies the brightness of the needle, making it clearly visible during a steep angle nerve block approach for deep targets, conditions under which the needle has previously been very difficult to image. The conference is being held in San Diego, California at the San Diego Convention Center, October 16-18, 2010
As a solution for the "lost needle phenomenon," which has been a well-known limitation in ultrasound needle imaging, anesthesiologists worldwide have quickly responded to Advanced Needle Visualization as a key tool for saving time, and improving patient safety. The algorithm enables physicians to increase confidence through visualization of the needle, which may result in less procedure time while maintaining fully-diagnostic image quality from near to far field, preserving anatomical detail.
… [Read more]
BOTHELL, WA - October 7, 2010 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, announced today that it will report the company's third quarter financial results on Thursday, October 21, 2010 at the close of market and will host a conference call at 1:30 p.m. PT/4:30 p.m. ET on that day. The call will be broadcast live and can be accessed via Sonosite’s website at www.sonosite.com/investorinformation/webcasts.
A replay of the audio webcast will be available beginning October 21, 2010 at 5:30 p.m. PT and can be accessed until November 4, 2010 at 9:59 p.m. PT by dialing (719) 457-0820 or toll-free (888) 203-1112. The confirmation code 7304277 is required to access the replay. Additionally, the call will be archived on Sonosite’s website.
About Sonosite
Sonosite, Inc. (www.sonosite.com) is the innovator and world leader in bedside and point-of-care ultrasound and an industry leader in ultra high-frequency micro-ultrasound technology and impedance cardiography equipment. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. Sonosite’s small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care.… [Read more]
BOTHELL, WA - September 2, 2010 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, said today that Kevin M. Goodwin, Sonosite's President and CEO, will present at the Stifel Nicolaus Healthcare Conference being held at the Four Seasons Hotel in Boston from September 15-17, 2010.
The session will be webcast live on Wednesday, September 15 at 11:30 am, Eastern Time. An audio replay will be available for 30 days following and can be accessed via Sonosite's website at www.sonosite.com/investorinformation/webcasts.
About Sonosite
Sonosite, Inc. (www.sonosite.com) is the innovator and world leader in bedside and point-of-care ultrasound and an industry leader in ultra high-frequency micro-ultrasound technology and impedance cardiography equipment. Headquartered near Seattle, the company is represented by fourteen subsidiaries and a global distribution network in over 100 countries. Sonosite's small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care.… [Read more]
First Generation Product Provides Unique Tracking and Guidance Technology for PICC Line Procedures
BOTHELL, WA - August 26, 2010 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, announced today that it received FDA clearance for its innovative LumenVu® Catheter Guidance System. Designed to aid in the placement of peripherally inserted central catheters (PICC), the proprietary LumenVu System combines near-infrared technology with a revolutionary fiber optic stylet, which replaces a traditional guide wire, to allow visualization and real-time tracking of a catheter tip as it advances through a vein.
"Receiving FDA clearance is an important milestone in the strategic development and global commercialization of the LumenVu System and it reinforces our dedication to providing patients with improved safety and health," said Kevin M. Goodwin, Sonosite's President and CEO.
"We envision this technology ultimately advancing beyond PICC line placements and potentially into a broader range of clinical applications. This clearance also represents a significant step towards the development of a fully integrated line placement imaging solution, which will include ultrasound visualization."… [Read more]
Mr. Cramer Will Remain on the Board as Chairman Emeritus Through the End of His Term in April 2011 Sonosite's Board Adopts a Smaller and More Simplified Structure for 2011
BOTHELL, WA - August 12, 2010 - Sonosite, Inc. (Nasdaq: SONO), the world leader and specialist in bedside and point-of-care ultrasound, today announced that Kirby L. Cramer is retiring as non-executive Chairman of the Board of Directors, effective August 12, 2010. As part of the Board's succession plan, Mr. Cramer will continue to serve as a director until Sonosite's 2011 annual meeting of shareholders. Sonosite's Board is naming Robert G. Hauser, M.D., F.A.C.C., F.H.R.S. to serve as non-executive Chairman of the Board. Mr. Cramer and Dr. Hauser will begin working together to create an orderly transition process over the next several weeks.
TRUSTED ADVISOR FOR TWELVE YEARS… [Read more]
UC Irvine Leadership Takes Medical Education to the Next Level by Integrating an Innovative Ultrasound Program and Curriculum
BOTHELL, WA - August 11, 2010 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, and the University of California, Irvine, announced today that the company and institution have signed an agreement to integrate ultrasound visualization into UC Irvine's four-year medical school curriculum.
Under the terms of this agreement, Sonosite will act as an exclusive ultrasound partner. The collaborative efforts of both UC Irvine and Sonosite will provide medical students with an active and dynamic learning experience that will transform traditional teaching methods used during medical school training. Sonosite's ultrasound systems will enable students to view anatomical structures in real-time and better understand physiological processes. This innovative ultrasound curriculum is setting the standard for other leading medical institutions and providing UC Irvine's students with the skill set and tools to improve medicine.… [Read more]
BOTHELL, WA - August 10, 2010 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside ultrasound for the point-of-care, today announced the retirement of Mike Schuh as Chief Financial Officer. Marcus Smith has been appointed as Senior Vice President and Chief Financial Officer and will replace Mr. Schuh as he retires from his position.
"I'm incredibly fortunate to have worked with such a visionary company and dedicated leadership team over the last ten years," said Mike Schuh. "Sonosite is truly transforming medicine and will continue to make significant contributions to the healthcare industry with its innovative technology and passionate culture that is focused on improving medicine."
"I want to thank Mike for his many contributions and ten years of dedication, hard work, and excellent service," said Kevin M. Goodwin, Sonosite's President and CEO. "Mike has been instrumental in establishing a successful financial infrastructure and serving as a trusted advisor. We wish him the best of luck in retirement."
A key member of Sonosite's executive team, Mr. Smith joined the company in 2007 as Vice President of Corporate Strategy and Growth Planning. He has since led the successful acquisition of Sonosite's primary care business while he served as Sonosite's Vice President and General Manager of Cardiovascular Disease Management.… [Read more]
Revenue Rises 18% EBIT Increases 145%, Excluding Acquisition Charges Gross Margins Rise to 72% Conference Call Webcast Live Today at 1:30 pm Pacific/4:30 pm Eastern
BOTHELL, WA - July 26, 2010 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried ultrasound for the point-of-care, today reported financial results for the second quarter and first half ended June 30, 2010.
REVENUE
Revenue increased 18% in the second quarter to $61.5 million and 13% for the first half of 2010 to $117.5 million, as compared to the prior year comparable periods. These comparisons included revenue of $3.8 million for the quarter and $7.0 million for the first half of 2010 from CardioDynamics (CDIC), which was acquired in the third quarter of 2009. SECOND QUARTER HIGHLIGHTS:
Revenue growth was led by Sonosite's US hospital channel, which was up 20%.
Revenue from the international business was impacted by a slowdown in Europe. The Company had steady performances in several other international markets and was up 2%. The International business sector profitability grew 7-8 times the "top line" growth rate, despite the slower revenue.
Pricing discipline and an improved product mix led to a 1.4 percentage point increase in gross margins to 72% for the quarter.
The Company had strong performances across all four vertical clinical markets.
EBIT and EBITDAS Second Quarter… [Read more]
Major Advancement for Regional Nerve Blocks and Other Injection Based Procedures
Highly Advanced Algorithms Were Developed Over Two Years and Aimed at Solving the Disappearing Needle Phenomenon in Anesthesia… [Read more]